Page 922 - Williams Hematology ( PDFDrive )
P. 922

896  Part VI:  The Erythrocyte                                                  Chapter 58:  The Porphyrias           897





                  Pathogenesis of the Clinical Findings                 also increased. Fecal porphyrins are increased, and are predominantly
                  Porphyrins in their oxidized state are reddish, fluorescent, and photo-  coproporphyrin I. Plasma total porphyrins are markedly increased as
                  sensitizing, whereas porphyrin precursors and the reduced porphyrin-  well, with a pattern of individual porphyrins similar to that in urine.
                  ogens are colorless and nonfluorescent. Most marrow normoblasts in   Markedly increased erythrocyte porphyrins are predominantly uropor-
                  CEP display marked fluorescence as a result of porphyrin accumula-  phyrin I and coproporphyrin I, although protoporphyrin IX may pre-
                  tion (located principally in the nuclei, probably because of fixation arti-  dominate especially in milder cases.
                  fact).  Anemia and the excess production and excretion of porphyrins   CEP must be distinguished by biochemical testing from other
                     92
                  is largely accounted for by ineffective erythropoiesis in the marrow.   causes of blistering skin lesions. HEP can present with photosensitivity
                  Porphyrin concentrations are also increased in circulating erythrocytes,   in early childhood. Mild cases of CEP may be misdiagnosed as PCT.
                  and intravascular hemolysis may result from exposure to light in the   The diagnosis should be confirmed in all cases by DNA studies,
                  dermal capillaries, causing erythrocyte damage and lysis or uptake by   which can identify causative mutations in almost all cases. This is espe-
                  the spleen. Splenomegaly is very common in CEP and is presumed to   cially important for genetic counseling and for prenatal diagnosis in
                  be secondary to the hemolytic process. The excess porphyrins that are   subsequent pregnancies. Demonstration of a GATA-1 mutation in one
                  produced by the marrow or released by hemolysis are transported in   case, illustrates that on occasion a genetic defect outside the heme bio-
                  plasma to the skin, leading to photosensitivity.      synthetic pathway can cause CEP. 93
                  Clinical Features                                     Therapy
                  Severe cutaneous photosensitivity is noted soon after birth in most cases.   Patients should be advised that to avoid severe scarring and loss of facial
                  The disease may be recognized even earlier as a cause of hydrops fetalis.   features and digits it is essential to avoid sunlight, trauma to the skin,
                  Phototherapy for hyperbilirubinemia may cause severe cutaneous burns   and infections. Topical sunscreens that block long-wave ultraviolet
                  and scarring in newborns with unrecognized CEP. Brown staining of   light (ultraviolet A light) and oral treatment with β-carotene are some-
                  the teeth by porphyrins (erythrodontia) is evident when the teeth erupt.   what helpful,  but are marginally beneficial in most cases. Erythrocyte
                                                                                  94
                  Blistering and scarring resemble those found in PCT, but are usually   transfusions are essential in patients with severe anemia.  Transfusions
                                                                                                                 95
                  much more severe, reflecting the much higher plasma porphyrin levels   to maintain the hematocrit above 35 percent, with an iron chelator to
                  observed in CEP. Some cases are relatively mild, and can closely mimic   avoid iron overload, has been beneficial in some cases.  Hydroxyurea
                                                                                                                96
                  PCT. Late-onset cases are often associated with myeloproliferative dis-  to reduce erythropoiesis and porphyrin production may also be con-
                  orders, with expansion of a clone of erythroid cells bearing a somatic   sidered.  Splenectomy has provided short-term benefit. Oral charcoal
                                                                              97
                  mutation and displaying UROS deficiency. 88           reportedly was quite effective in one patient,  and ascorbic acid and
                                                                                                          98
                     Subepidermal  bullous  lesions  are  characteristic,  and  progress  to   α-tocopherol improved anemia in another.  Unaffected infants born to
                                                                                                       89
                  crusted erosions that heal with scarring and areas of hyper- and hypop-  mothers with CEP may have erythrodontia as a result of exposure to
                  igmentation. Also common is hypertrichosis, which is sometimes   maternal porphyrins before birth. 99
                  severe, and alopecia. Loss of facial features and digits are common and   Hematopoietic stem cell transplantation is the treatment of choice
                  result from recurrent blisters, infection, and scarring. Fingers may be   when  a  suitable  donor  is  available,  especially  for  young  patients.
                                                                                                                          100
                  shortened and tapered as a consequence of scarring and contraction of   When transplantation is successful, there is marked clinical improve-
                  the skin during childhood growth. Erythrodontia, with brown staining   ment and reduction in porphyrin levels, even if these are not completely
                  and red fluorescence of the teeth under long-wave ultraviolet light is   normalized. Gene therapy is being explored using retroviral and lenti-
                  characteristic, and results from deposition of porphyrins in the develop-  viral vectors and hematopoietic stem cells from patients with CEP. 101,102
                  ing deciduous and permanent teeth in utero. Porphyrins are also depos-
                  ited in bone. The skeleton is also affected by expansion of the marrow,   ERYTHROPOIETIC PROTOPORPHYRIA
                  leading to pathologic fractures, vertebral compression, short stature,
                  and osteolytic and sclerotic lesions. Vitamin D deficiency resulting from   Definition and History
                  avoiding sunlight might also contribute.              EPP is caused by a partial deficiency of FECH (see Fig. 58–4, step 8)
                     Anemia may be severe and lead to transfusion dependence in the   activity, which results in the accumulation of the substrate protopor-
                  more severe cases. Uncorrected anemia can increase erythropoiesis,   phyrin in the marrow. XLP has the same phenotype but is much less
                  which, in turn, is a stimulus to porphyrin production by the abnormal   common, and is a result of ALAS2 gain-of-function mutations (ALAS;
                                                                                   37
                  erythropoietic cells in the marrow. Erythrocytes exhibit polychromasia,   see Fig. 58–1).  EPP and XLP are characterized by onset of nonblis-
                  poikilocytosis, anisocytosis, and basophilic stippling, and reticulocytes   tering cutaneous photosensitivity in early childhood. EPP is the most
                  and nucleated red blood cells are increased. 93       common porphyria in children and the third most common in adults.
                                                                        Reported prevalence varies between 5 and 15 cases per 1 million indi-
                  Diagnosis                                             viduals. 103–105  Protoporphyric hepatopathy is a potentially fatal compli-
                  CEP may be suspected even before birth if a sibling is known to have   cation estimated to occur in less than 5 percent of patients.
                  CEP. However, the family history is often negative. CEP should be sus-
                  pected as a cause of hydrops fetalis, as the disease can be diagnosed and   Pathophysiology
                  treated in utero. Aspirated amniotic fluid is dark brown in color and   In most families, EPP is best described as an autosomal recessive dis-
                  contains large amounts of porphyrins. The diagnosis of CEP is often   ease, in which a severe FECH mutation is inherited from one parent and
                  made after birth when pink to dark-brown staining of the diapers, with   a low-expression (hypomorphic) FECH allele from the other. More than
                  red fluorescence under long-wave ultraviolet light, is noted. Cutaneous   75 different severe mutations, including nonsense, missense, and splice-
                  vesicles and bullae on sun-exposed areas may be severe, with scarring.  site mutations, and deletions, insertions, and rearrangements have been
                     Urinary porphyrin excretion is markedly increased, and often in   described. Splicing mutations are most common. Recombinant human
                  the range of 50 to 100 mg/day (normal: up to ~0.3 mg/day). Uroporphy-  FECH, when engineered to have individual exon skipping for exons 3
                  rin I and coproporphyrin I account for most of the increase, although   through 11, lacks significant enzyme activity when expressed in E. coli
                  the III isomers and hepta-, hexa-, pentacarboxylate porphyrins are   and almost all such variants lacked the [ Fe- S] cluster. 106
                                                                                                     2
                                                                                                        2





          Kaushansky_chapter 58_p0889-0914.indd   897                                                                   9/18/15   5:58 PM
   917   918   919   920   921   922   923   924   925   926   927